Free Trial
NASDAQ:TECX

Tectonic Therapeutic Q4 2024 Earnings Report

Tectonic Therapeutic logo
$21.75 +2.09 (+10.63%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$22.50 +0.75 (+3.45%)
As of 05/2/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tectonic Therapeutic EPS Results

Actual EPS
-$0.84
Consensus EPS
-$1.39
Beat/Miss
Beat by +$0.55
One Year Ago EPS
N/A

Tectonic Therapeutic Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tectonic Therapeutic Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Thursday, March 20, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Tectonic Therapeutic's Q1 2025 earnings is scheduled for Thursday, May 8, 2025

Tectonic Therapeutic Earnings Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Tectonic Therapeutic initiated with an Outperform at Mizuho
See More Tectonic Therapeutic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tectonic Therapeutic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tectonic Therapeutic and other key companies, straight to your email.

About Tectonic Therapeutic

Tectonic Therapeutic (NASDAQ:TECX), Inc. engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.

View Tectonic Therapeutic Profile

More Earnings Resources from MarketBeat